Percentile ranking and citation impact of a large cohort of National Heart, Lung, and Blood Institute-funded cardiovascular R01 grants.

PubWeight™: 2.08‹?› | Rank: Top 2%

🔗 View Article (PMC 3959724)

Published in Circ Res on January 09, 2014

Authors

Narasimhan Danthi1, Colin O Wu, Peibei Shi, Michael Lauer

Author Affiliations

1: From the Advanced Technologies and Surgery Branch (N.D.), the Office of Biostatistics Research (C.O.W., P.S.), and the Office of the Director (M.L.), Division of Cardiovascular Sciences of the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD.

Articles citing this

Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level. PLoS Biol (2016) 2.72

How to make more published research true. PLoS Med (2014) 2.55

Predatory publishing, questionable peer review, and fraudulent conferences. Am J Pharm Educ (2014) 2.34

To apply or not to apply: a survey analysis of grant writing costs and benefits. PLoS One (2015) 1.54

Examining the Predictive Validity of NIH Peer Review Scores. PLoS One (2015) 1.45

Impact of National Heart, Lung, and Blood Institute-Supported Cardiovascular Epidemiology Research, 1998 to 2012. Circulation (2015) 1.42

Prior publication productivity, grant percentile ranking, and topic-normalized citation impact of NHLBI cardiovascular R01 grants. Circ Res (2014) 1.35

Research Funding: the Case for a Modified Lottery. MBio (2016) 1.32

The validation of peer review through research impact measures and the implications for funding strategies. PLoS One (2014) 1.06

Competitive science: is competition ruining science? Infect Immun (2015) 1.01

Citation impact of NHLBI R01 grants funded through the American Recovery and Reinvestment Act as compared to R01 grants funded through a standard payline. Circ Res (2015) 0.98

NIH peer review percentile scores are poorly predictive of grant productivity. Elife (2016) 0.98

Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation. Circ Res (2017) 0.96

Personal reflections on big science, small science, or the right mix. Circ Res (2014) 0.90

Association of percentile ranking with citation impact and productivity in a large cohort of de novo NIMH-funded R01 grants. Mol Psychiatry (2015) 0.85

Predicting Productivity Returns on Investment: Thirty Years of Peer Review, Grant Funding, and Publication of Highly Cited Papers at the National Heart, Lung, and Blood Institute. Circ Res (2015) 0.82

Bibliometric analysis of the top-cited gastroenterology and hepatology articles. BMJ Open (2016) 0.79

Biases in grant proposal success rates, funding rates and award sizes affect the geographical distribution of funding for biomedical research. PeerJ (2016) 0.75

Lost in Translation. JACC Cardiovasc Interv (2015) 0.75

The Influence of Peer Reviewer Expertise on the Evaluation of Research Funding Applications. PLoS One (2016) 0.75

Articles by these authors

Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med (2012) 3.93

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med (2011) 3.82

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med (2015) 3.42

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood (2006) 2.69

NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. Am J Respir Crit Care Med (2015) 2.60

High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the multiethnic study of atherosclerosis. Am Heart J (2012) 2.18

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood (2013) 1.97

Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension (2010) 1.91

Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA (2010) 1.86

Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J Clin Oncol (2008) 1.84

Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. J Clin Oncol (2010) 1.79

Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica (2009) 1.73

Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension (2013) 1.61

Prevalence and incidence of hypertension in adolescent girls. J Pediatr (2010) 1.51

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol (2008) 1.49

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Soc Echocardiogr (2009) 1.45

Engaging patients and stakeholders in research proposal review: the patient-centered outcomes research institute. Ann Intern Med (2014) 1.44

Age-related changes in aortic arch geometry: relationship with proximal aortic function and left ventricular mass and remodeling. J Am Coll Cardiol (2011) 1.42

Intravascular thermographic assessment in human coronary atherosclerotic plaques by a novel flow-occluding sensing catheter: a safety and feasibility study. J Invasive Cardiol (2005) 1.39

Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J (2013) 1.32

N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail (2012) 1.31

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging (2009) 1.30

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica (2010) 1.25

Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr (2008) 1.22

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica (2009) 1.20

Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis (2011) 1.16

Pleiotropy analysis of quantitative traits at gene level by multivariate functional linear models. Genet Epidemiol (2015) 1.16

Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients. Exp Hematol (2008) 1.15

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies. Biol Blood Marrow Transplant (2010) 1.14

Effect of functional health-related quality of life on long-term survival after cardiac surgery. Circulation (2007) 1.13

Age, sex, and hypertension-related remodeling influences left ventricular torsion assessed by tagged cardiac magnetic resonance in asymptomatic individuals: the multi-ethnic study of atherosclerosis. Circulation (2012) 1.10

Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care (2002) 1.08

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood (2011) 1.04

Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J Mol Cell Cardiol (2009) 1.02

Inter-study reproducibility of cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson (2013) 1.01

Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study. Circ Cardiovasc Imaging (2014) 0.97

Joint analysis of binary and quantitative traits with data sharing and outcome-dependent sampling. Genet Epidemiol (2012) 0.96

Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis. Radiology (2014) 0.95

Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. Am Heart J (2008) 0.92

Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes (2012) 0.89

National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025. Am J Public Health (2015) 0.89

Linkage analyses of rheumatoid arthritis and related quantitative phenotypes: the GAW15 experience. Genet Epidemiol (2007) 0.87

Proceedings of the Christiana Care Health System Value Institute Value Symposium. Am J Med Qual (2012) 0.86

Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia. Am J Hematol (2014) 0.83

Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys (2006) 0.82

Diastolic function assessed from tagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: the multi-ethnic study of atherosclerosis. Eur Heart J Cardiovasc Imaging (2013) 0.80

First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study. Cardiovasc Revasc Med (2007) 0.80

When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption. J Comp Eff Res (2013) 0.80

The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Magn Reson (2015) 0.79

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. Circ Cardiovasc Imaging (2009) 0.79

Reply: Resting heart rate: an independent predictor of congestive heart failure. J Am Coll Cardiol (2014) 0.78

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Cardiovasc Comput Tomogr (2009) 0.78

Reviewing hypothetical migraine studies using funding criteria from the Patient-Centered Outcomes Research Institute. Health Aff (Millwood) (2012) 0.77

NHLBI clinical trials workshop: an executive summary. Stat Med (2012) 0.76

Comparing strategies for evaluation of candidate genes in case-control studies using family data. BMC Proc (2007) 0.75

Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia. Am J Hematol (2014) 0.75

Coronary 64-slice computed tomographic angiography models employing aortic root and selective catheter directed contrast enhancement in swine: technical feasibility and preliminary results using 3D and 4D reconstructions. Int J Cardiovasc Imaging (2006) 0.75

Cost effectiveness of biventricular pacemakers in heart failure patients. Am J Cardiovasc Drugs (2006) 0.75

Preface. Randomized clinical trials. Stat Med (2012) 0.75

Panel discussion 1. Clin Trials (2012) 0.75